Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy of Trilaciclib and Lurbinectidin
- Where
- Chapel Hill, Lebanon
- Age
- 18 years and over
- People
- 30
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT05578326 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Aurora, Beverly Hills, Boston, Chicago, Duarte, Fairfax, Greenville, Houston, Iowa City, Louisville, Miami, Nashville, New Haven, New York, Orange, Orlando, Port Saint Lucie, Santa Monica, Seattle, Washington D.C.
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - Phase 1Taking peoplePersonalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
- Where
- Columbus, Orlando, St Louis
- Age
- 18 years and over
- People
- 64
- Run by
- Washington University School of Medicine
See details and how to joinNCT06529822 - Phase 2Taking peopleProspective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
- Where
- Baltimore, Baton Rouge, Memphis, Nashville, Pinehurst, Salisbury, Tampa, The Bronx
- Age
- 18 years and over
- People
- 318
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06745882 - No phaseTaking peopleSocial Optimization Study
- Where
- Tucson
- Age
- 18 years to 99 years
- People
- 30
- Run by
- University of Arizona
See details and how to joinNCT07564960 - Phase 1/2Taking peopleA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Where
- Ann Arbor, Baton Rouge, Boston, Fairfax, Hackensack, Houston, Nashville, New York, Sarasota, Tampa
- Age
- 18 years and over
- People
- 265 worldwide
- Run by
- Blueprint Medicines Corporation
See details and how to joinNCT07629960 - No phaseTaking peopleEmpowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
- Where
- Alpharetta, Anaheim, Atlanta, Buford, Costa Mesa, Decatur, Duluth, Dunwoody, Irvine, Johns Creek, Jonesboro, La Grange, Laguna Hills, Lilburn, Lithonia, Marietta, Newport Beach, Orange, Peachtree City, Santa Ana, Sharpsburg, Smyrna, Snellville, Stockbridge, Stone Mountain, Tucker, Tustin, Warner Robins, West Point, Yorba Linda
- Age
- 50 years to 80 years
- People
- 80
- Run by
- University of California, Irvine
See details and how to joinNCT07711691 - Phase 1Taking peopleFecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04038619 - No phaseEnrolling by invitationDevelopment and Analysis of a Stool Bank for Cancer Patients
- Where
- Fountain Valley, Winter Haven
- Age
- 18 years and over
- People
- 100
- Run by
- Persephone Biosciences
See details and how to joinNCT04291755 - Phase 1/2Taking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Austin, Grand Rapids, Houston, Huntersville, Miami, Minneapolis, Nashville, Salt Lake City, San Antonio, St Louis
- Age
- 18 years and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - Phase 3Taking peopleClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Where
- Abilene, Alameda, Anaheim, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Beverly Hills, Blacksburg, Boston, Brighton, Carterville, Cerritos, Chandler, Chapel Hill, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Covington, Dallas, Denver, Detroit, Duluth, Durham, Eugene, Evanston, Fairfax, Fort Lauderdale, Fort Worth, Foxborough, Grand Junction, Greenville, Hattiesburg, Hot Springs, Houston, Indianapolis, Jacksonville, Jacksonville Beach, Jonesboro, Kansas City, Lebanon, Lexington, Lone Tree, Los Angeles, Loveland, Methuen, Milford, Minneapolis, Mullica Hill, Nashville, New Brunswick, New York, North Venice, Ocala, Oklahoma City, Orange, Orlando, Oxnard, Pensacola, Philadelphia, Phoenix, Pinehurst, Pittsburgh, Plantation, Portland, Richmond, Saint Paul, Salt Lake City, San Diego, Seattle, St Louis, St. Petersburg, Sunnyvale, Syracuse, Tallahassee, Tamarac, The Bronx, Torrance, Tyler, Vancouver, Warner Robins, Waukee, Webster, West Palm Beach, Weymouth, Worcester
- Age
- 18 years and over
- People
- 780 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT06767514 · EU 2024-518629-14-00 - Phase 2Taking peopleA Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
- Where
- Anchorage, Boston, Canton, Detroit, Milwaukee, New York, Portland, Seattle, St Louis
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06855771 · EU 2024-519814-29-00 - Phase 1/2Taking peopleNBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07224152 - Phase 1Taking peopleAQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 102 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT07617337 - Phase 2Taking peopleRMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- Where
- Brainerd, Deer River, Detroit Lakes, Duluth, Fosston, Hibbing, Minneapolis, Phoenix, Sandstone, Virginia
- Age
- 18 years and over
- People
- 82
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT04105270 - No phaseTaking peopleProspective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
- Where
- Atlanta
- Age
- 18 years and over
- People
- 30
- Run by
- Emory University
See details and how to joinNCT04342429 - No phaseEnrolling by invitationPrecision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment
- Where
- St Louis
- Age
- 18 years and over
- People
- 915
- Run by
- Washington University School of Medicine
See details and how to joinNCT05627674 - Phase 1Taking peopleA Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Where
- Duarte, Glen Burnie, Grand Rapids, Houston, Iowa City, Irvine, Miami, New York, Orlando, Pittsburgh, Salt Lake City, Tampa, Westwood
- Age
- 18 years and over
- People
- 150
- Run by
- Aktis Oncology, Inc.
See details and how to joinNCT07020117 - Phase 1Taking peopleStudy of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Where
- Baltimore, Boston, Dallas, Fairfax, Grand Rapids, New Haven, New York, San Antonio
- Age
- 18 years and over
- People
- 574
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07349537 - Phase 1/2Taking peopleA Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
- Where
- Fairfax, Houston, Louisville, Plantation, Washington D.C.
- Age
- 18 years and over
- People
- 118 worldwide
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07407933 - Phase 2Taking peoplePharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 60
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07685938 - Phase 3Taking peoplePhase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Where
- Grand Rapids, Omaha, Orlando
- Age
- 18 years to 99 years
- People
- 400 worldwide
- Run by
- Amgen
See details and how to joinNCT07778316 - No phaseTaking peopleA Study Evaluating a New Radiation Treatment Workflow (NGDS)
- Where
- Cleveland, St Louis
- Age
- 21 years and over
- People
- 20
- Run by
- Varian, a Siemens Healthineers Company
See details and how to joinNCT07824583 - Phase 1/2Taking peopleQuaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- Where
- Canton, Fairfax, Houston, Lexington, Lone Tree, Los Angeles, Norfolk, Paramus, Rockville, Urbana
- Age
- 18 years and over
- People
- 158
- Run by
- Genprex, Inc.
See details and how to joinNCT04486833 - No phaseTaking peopleCardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation
- Where
- Houston
- Age
- 18 years and over
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05010109